Mohamed Aziz-Abdel
Al Minya, MN 61768, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Harnessing Substituted 4-Chlorothieno[2,3-b]pyridine as a New Cap for Potent and Selective Antiproliferative HDAC Inhibitors.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 12, 2026
Phenylpiperazine/dithioates as novel H2S donors: design, synthesis, H2S release, formulation as PEG-niosomes and antifungal activity against Candida albicans.
Journal: Bioorganic chemistry
Published: November 20, 2025
Ferroptosis-Driven Anticancer Activity of 1,3,4-Oxadiazole-Benzimidazole/Acetamide Hybrids: Design, Synthesis, and Biological Profiling.
Journal: Archiv der Pharmazie
Published: September 06, 2025
Novel pyrazole-oxadiazole-chalcone/oxime hybrids as dual EGFR/VEGFR-2 inhibitors with promising anticancer potential: a comprehensive cytotoxicity evaluation, mechanistic insights and SAR analysis.
Journal: Molecular diversity
Published: September 04, 2025
Rational design of 2-substituted thio-7-chloroquinazolin-4(3H)-one derivatives as dual EGFR/VEGFR-2 inhibitors with broad-Spectrum anticancer and apoptotic activities.
Journal: Bioorganic chemistry
Published: August 21, 2025
Biologically Active Benzimidazole Hybrids as Cancer Therapeutics: Recent Advances.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 13, 2025
Design, Synthesis, and Biological Evaluation of Novel Benzimidazole/Schiff Base Hybrid Derivatives With Potential Biological Activities.
Journal: Archiv der Pharmazie
Published: August 05, 2025
Design, synthesis, and biological evaluation of novel 1,5-diarylpyrazole carboxamides with dual inhibition of EGFR and COX-2 for the treatment of cancer and inflammatory diseases.
Journal: Bioorganic & medicinal chemistry letters
Published: July 17, 2025
Design, Synthesis, and In Vitro Anticancer Evaluation of Thiazole-Based Chalcones Linked to Sulfanilamide as Tumor-Associated Carbonic Anhydrase IX and XII Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 07, 2025
Targeting melanoma resistance: Novel oxindole and non-oxindole-based benzimidazole derivatives as potent dual inhibitors of BRAFV600E and ABL2 kinases.
Journal: European journal of medicinal chemistry
Published: June 17, 2025
Unveiling ortho-phenolic Mannich ciprofloxacin-chalcone conjugates with potential antineoplastic activity: synthesis, mechanistic study, in silico docking and molecular dynamic simulation.
Journal: European journal of medicinal chemistry
Published: April 22, 2025
Last Updated: 09/26/2026